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1. Introduction
Ion computed tomography (iCT) represents a promising solution for direct assessment of the relative (to water) 
ion stopping power (RSP). Thereby, uncertainties of 1%–3% inherent in the semi-empirical conversion of x-ray 
CT (xCT) Hounsfield units (HU) into RSP (Paganetti 2012, Yang et al 2012) could be eliminated. This would allow 
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Abstract
Ion computed tomography (iCT) represents a potential replacement for x-ray CT (xCT) in ion 
therapy treatment planning to reduce range uncertainties, inherent in the semi-empirical conversion 
of xCT information into relative stopping power (RSP). In this work, we aim to quantify the 
increase in dosimetric accuracy associated with using proton-, helium- and carbon-CT compared 
to conventional xCT for clinical scenarios in proton therapy. Three cases imaged with active beam-
delivery using an ideal single-particle-tracking detector were investigated using FLUKA Monte-Carlo 
(MC) simulations. The RSP accuracy of the iCTs was evaluated against the ground truth at similar 
physical dose. Next, the resulting dosimetric accuracy was investigated by using the RSP images as 
a patient model in proton therapy treatment planning, in comparison to common uncertainties 
associated with xCT. Finally, changes in relative biological effectiveness (RBE) with iCT particle 
type/spectrum were investigated by incorporating the repair-misrepair-fixation (RMF) model into 
FLUKA, to enable first insights on the associated biological imaging dose. Helium-CT provided the 
lowest overall RSP error, whereas carbon-CT offered the highest accuracy for bone and proton-CT 
for soft tissue. For a single field, the average relative proton beam-range variation was  −1.00%, 
+0.09%, −0.08% and  −0.35% for xCT, proton-, helium- and carbon-CT, respectively. Using a 
0.5%/0.5mm gamma-evaluation, all iCTs offered comparable accuracy with a better than 99% 
passing rate, compared to 83% for xCT. The RMF model predictions for RBE for cell death relative 
to a diagnostic xCT spectrum were 0.82–0.85, 0.85–0.89 and 0.97–1.03 for proton-, helium-, and 
carbon-CT, respectively. The corresponding RBE for DNA double-strand break induction was 
generally below one. iCT offers great clinical potential for proton therapy treatment planning by 
providing superior dose calculation accuracy as well as lower physical and potentially biological dose 
exposure compared to xCT. For the investigated dose level and ideal detector, proton-CT and helium-
CT yielded the best performance.
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for a reduction of the related safety margins for improving the clinical outcome of patients receiving ion therapy 
treatments. In order to potentially replace x-ray imaging for proton therapy treatment planning, iCT must 
provide competitive image quality and dose calculation accuracy without enhancing the imaging dose exposure. 
This would open new perspectives for adaptive ion therapy with on-isocenter low dose imaging (Landry and Hua 
2018). While dual-energy CT demonstrates already clinically promising results (Wohlfahrt et al 2017) in terms of 
reduced range uncertainties, iCT is the intuitive solution providing better RSP accuracy (Hansen et al 2015) with 
the possibility of imaging directly at the beam isocenter.  Furthermore, iCT image quality is not affected by metal 
artifacts (Oancea et al 2018). Various groups worldwide are currently investigating ion imaging with a dedicated 
focus on proton beams (Johnson 2018). In contrast, heavier ions can yield improved image quality by benefiting 
from reduced multiple Coulomb scattering (MCS) (Hansen et al 2014, Volz et al 2017). However, they also 
exhibit an increased physical dose per particle and suffer from an elevated loss of primaries due to fragmentation, 
ultimately affecting the noise of iCT (Gehrke et al 2018). A comparison of different particle types for iCT, 
including image quality and range accuracy for proton therapy treatment planning in realistic clinical scenarios, 
remains unstudied. Additionally, a detailed assessment of the biological impact of typical iCT acquisitions is 
required, since ion beams can have elevated linear energy transfer (LET) spectra compared to sparsely ionizing 
x-rays. In this study, we addressed the image quality of proton- (pCT), helium- (heCT) and carbon-CT (cCT) in 
clinical scenarios using a dedicated, experimentally validated Monte-Carlo (MC) simulation framework (Meyer 
et al 2017). The associated dose calculation accuracy was quantified using the RayStation treatment planning 
system. Furthermore, an approach for coupling the MC-code to the mechanistic repair-misrepair-fixation 
(RMF) model (Carlson et al 2008) was implemented to derive the relative biological effectiveness (RBE) for the 
iCT simulations. The different scenarios were compared to the established practice using xCT both in terms of 
RSP uncertainties and imaging dose.
2. Materials and methods
2.1. iCT simulation and reconstruction
Current iCT prototypes are optimized for imaging of the human head (Bashkirov et al 2016), due to presently 
available maximum beam energies and the required small field of view. Furthermore, the heterogeneities and 
large variation of RSP from air cavities to bony structures represent a challenging anatomy that requires accurate 
imaging for treatment planning.
Hence, three representative cranial patient cases with clinical xCTs were investigated: a left frontobasal ana-
plastic astrocytoma (Pat1), a nasopharynx cancer (Pat2) and a left sided glioblastoma (Pat3). The iCT simula-
tions were performed using the FLUKA MC-code (Ferrari et al 2005, Böhlen et al 2014) (version 2011.2c.6 using 
HADROTHE defaults without explicit δ-ray production) with customized user routines in order to mimic a 
realistic scanned beam with an experimentally validated beam model (Tessonnier et al 2016). In this work, we 
simulated an ideal detector represented by two scoring planes recording position, direction and energy of each 
individual ion. These trackers each covered an area of 30× 30 cm2 and are located prior and posterior to the 
imaged patient volume, 45 cm from the isocenter as in a realistic clinical scenario. The initial energy was set to 
the nominal beam energy E222 of the Heidelberg Ion-Beam Therapy Center, which corresponds to a range in 
water of ~26 cm for each of the ions, being hypothetically detectable with existing prototype detector systems 
(Giacometti et al 2017). A total of 400 protons, 100 helium ions or 20 carbon ions were simulated per irradiation 
spot for 180 projections, resulting in a ~1.9 mGy physical dose for each case, which is much lower than typical 
values between 10 mGy and 100 mGy in xCT (Murphy et al 2007). The spot spacing was chosen in accordance 
with the resolution of the patient xCT data, i.e. 1.074 mm and 3 mm in the horizontal and vertical direction, 
respectively. The xCTs in DICOM format were imported in FLUKA and converted to the RSP ground truth by 
forcing the MC-code to follow a bijective and error-free clinical-like HU-RSP conversion curve (Parodi et al 
2007). In contrast to a real patient scenario, the HU-RSP curve employed in an MC simulation does not contain 
any uncertainty, since it is defined by the user and is in this work monotonic and bijective. Based on the knowl-
edge of the conversion curve, the patient’s xCT anatomy is converted into RSP without uncertainty, thus defining 
the ground truth reference map. Hence, the exact RSP distribution of the simulated patient anatomy in FLUKA 
is known. The only remaining uncertainty in the presented approach originates from the energy dependency of 
RSP which is negligible for the used energies (Arbor et al 2015).
For tomographic image reconstruction of the iCTs, the iterative ordered-subset simultaneous algebraic 
reconstruction technique (Wang and Jiang 2004) with incorporated cubic spline path (CSP) estimate (Collins-
Fekete et al 2015) and total variation superiorization was implemented. Furthermore, the common 3σ data cuts 
(Schulte et al 2008) were used for the retrieved events. To account for the patient’s surrounding air gap, a hull 
contour derived from the xCT data was used (Collins-Fekete et al 2017a). The reconstruction was stopped if 
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the derivative (with respect to the iteration number) of the average Euclidean data divergence was either below 
2 · 10−6 (cCT), 1 · 10−7 (heCT) and 1 · 10−8 (pCT)11, or after 30 iteration cycles through all particle histories 
were completed.
The overall image quality for a reconstructed slice was assessed with respect to the known ground truth using 
the RSP relative error  (Penfold et al 2010) defined as
 =
∑
i |xi − xi|∑
i xi
,
where xi and xi are the RSP values in voxel i of the reconstructed and ground truth image (obtained from the 
patient anatomy of the xCT and the HU-RSP conversion of the MC simulation), respectively. The joint histogram 
of the reconstructed iCT and the original HU values in the corresponding ground truth enabled the calculation 
of the RSP precision as a measure of noise of the iCT images.
2.2. FLUKA-RMF coupling for RBE prediction
In the RMF model, developed by Carlson et al (2008), double-strand break (DSB) induction and processing are 
explicitly linked with reproductive cell death. For a given particle radiation, the terms of the linear-quadratic 
(LQ) model can be derived from the formalisms presented in Frese et al (2012) and Kamp et al (2015) using the 
tissue-specific LQ radiosensitivity parameters (αX  and βX), the initial number of induced DSBs (Σ) and the 
frequency-mean specific energy (zF ) for the reference radiation and the considered radiation.
MC damage simulation (MCDS) (Semenenko and Stewart 2004, Stewart et al 2011) (version 3.10A with 
default settings) was used to predict Σ and zF  as a function of particle type and energy under normoxic condi-
tions. The corresponding parameters for the reference radiation were obtained by simulating the secondary elec-
tron energy spectrum of a 60Co source (Hsiao and Stewart 2008) (ΣX = 8.2706Gbp−1 Gy−1, zF,X = 0.0019Gy).
In order to account for the RBE of different ion types and energy spectra, the RMF-derived predictions of 
the LQ parameters were coupled to the FLUKA MC-code following the approach of Mairani et al (2010). In 
each voxel, the RBE for cell death (RBERMF) can be calculated from the dose-weighted average LQ radiosen-
sitivity parameters and the RBE for DSB induction (RBEDSB) can be computed using MCDS. For performing 
an online adaption of the tissue-specific radiosensitivity parameters within the framework of the RMF model, 
we adapted the approach of Kamp et al (2017). In a similar manner, the reference radiation quality (i.e. ΣX 
and zF,X) can be changed. This feature was exploited to calculate the biological dose response for a diagnostic 
130 kVp x-ray energy spectrum obtained for a tungsten anode with 0.8 mm beryllium filtration (Stewart et al 
2015) (ΣX = 10.4749Gbp−1 Gy−1, zF,X = 0.0392Gy12) as reference imaging radiation. This previously investi-
gated setting can serve as the best-case scenario for xCT, yielding slightly reduced biological effects in comparison 
to the more typically chosen tube voltage of 120 kVp for x-ray imaging treatment planning.
2.3. Treatment planning and dose calculation
For each case, proton therapy treatment plans using pencil beam scanning were optimized on the RSP ground 
truth obtained from the imported xCT anatomy. A research version of the commercial treatment planning 
system RayStation (RaySearch Laboratories, Sweden) was used for all dose calculations of the treatment planning 
comparison within this work. The derived treatment plans were recalculated in RayStation using the simulated 
iCTs. Since RayStation does not currently support direct RSP import, the reconstructed RSP images were 
converted into HUs using the inverse of the HU-RSP conversion curve of the MC-code, relying on the imposed 
bijectivity of that function. Subsequently, all images were imported in the treatment planning system using the 
same internal conversion to density and RSP, eliminating possible uncertainties related to the image import. 
This procedure allows a consistent comparison independent of the fact that the conversion exploited in the MC 
simulation is different from the one of the TPS. In order to emulate the typical uncertainties encountered for the 
HU-RSP conversion using conventional xCT, we additionally imported the xCTs by randomly introducing an 
error (using a continuous distribution from  −3% to 3%) to the RSP values of the conversion curve. We chose a 
curve that systematically overestimates the RSP for soft tissue while underestimating it for bone, in agreement 
with findings of Wohlfahrt et al (2017).
The obtained results were compared to the original (planned) dose distributions by means of beam’s-eye 
view range difference maps for single field uniform doses, dose-volume histograms and global 3D gamma evalu-
ation (Podesta et al 2014) (using a 10% low-dose threshold) for multi-field intensity modulated proton therapy 
plans. The single field plans were chosen in a way to represent cases of large heterogeneities (Pat1) as well as more 
homogeneous beam paths with long (Pat2) and short penetration depth (Pat3). The obtained range differences 
were converted into a water-equivalent range by performing a raytracing between the 80% distal dose points and 
11 The chosen values yield the best compromise between convergence and noise for the different particle statistics.
12 zF,X  for a spherical water target was approximated by zF,X = 0.204
LET
d2tar
Ä
keV
µm3
ä
 with dtar = 5µm (Carlson et al 2008).
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weighting the intersected voxels with the RSP of the ground truth (Wohlfahrt et al 2017). To obtain relative range 
shifts, the values were divided by the corresponding water-equivalent range for the reference scenario.
3. Results
3.1. Evaluation of iCT image quality
Figure 1 shows axial slices of the reconstructed iCTs and the related RSP relative errors. In general, heCT exhibits 
superior image quality in terms of reduced RSP error, being on average 0.2% and 0.3% lower than for pCT 
and cCT, respectively. For heterogeneous regions like the paranasal sinuses or nasal cavities (e.g. slice 28–35 
in figure 1(J)), an increased relative error becomes evident. In regions mainly containing homogeneous brain 
tissue, (e.g. slice 42–47 in figure 1(J)), the pCT image quality exceeds that of the cCT and yields RSP relative errors 
comparable to the heCT. When using the same statistics for pCT and heCT as for cCT, the average RSP relative 
error over all reconstructed slices was 6.6%, 1.7% and 1.3% for pCT, heCT and cCT, respectively.
Figure 2 displays the obtained RSP distribution for Pat3, demonstrating good agreement with the ground 
truth HU-RSP conversion curve. pCT and cCT show worse RSP precision in terms of an increased standard 
deviation, being 1.3 times higher than for heCT. In the zoom-in plots of figure 2, the reconstructed RSP is under-
estimated for bony materials (−2.1%, −1.2% and  −0.4% at 1500 HU for pCT, heCT and cCT, respectively) and 
overestimated for fat and soft tissue (+0.5%, +0.9% and  +1.2% at 0 HU).
3.2. Assessment of range accuracy
For single field uniform dose proton therapy plans, figure 3 shows the observed range variations, calculated 
as water-equivalent differences in the position of the 80% distal dose falloff in beam’s-eye view between 
planned (ground truth) and recalculated (iCTs and xCT) dose distribution. All iCT cases show sub-millimeter 
accuracy with an average (±1 s.d.) relative proton-beam range error of (+0.09  ±  0.33)%, (−0.08  ±  0.24)% 
and (−0.35  ±  0.26)% for pCT, heCT and cCT, respectively. This corresponds to a water-equivalent range 
error of (+0.07  ±  0.18) mm, (−0.08  ±  0.14) mm and (−0.29  ±  0.18) mm. For the pCT data set of Pat2, over-
ranging above 1.0% was observed for pencil beams traversing the nasal cavities. The range error for xCT was 
(−1.00  ±  0.43)% and (−0.84  ±  0.32) mm.
3.3. Comparison of dosimetric outcome
The dosimetric comparison based on clinical multi-field intensity modulated proton therapy plans is presented 
in figure 4. The obtained iCT dose-volume histograms were in notable agreement with the reference and 
variations in D2% and D98% were not exceeding 15 cGy for organs at risk. By contrast, variations of up to 200 cGy 
were observed for xCT. For a 0.5%/0.5mm gamma-evaluation, xCT exhibited an average passing rate of 83% 
increasing to better than 99% for all iCTs.
3.4. Estimation of biological dose exposure
Table 1 lists the mean RBE predictions for the three iCT simulation scenarios for the biological endpoints 
of DSB induction and cell death. RBEDSB was 1.4%, 1.8% and 2.3% lower than RBERMF assuming an α/β  of 
10 Gy for pCT, heCT and cCT, respectively. The corresponding unrestricted dose-averaged LET values (in 
water) (Bauer et al 2014) were 2.33 keV µm−1, 4.00 keV µm−1 and 11.85 keV µm−1. On average (including all 
presented biological modeling), the RBE for pCT was 3.8% lower than for heCT and 18.9% lower than for cCT.
4. Discussion
In the presented study, we demonstrated that iCT can provide accurate RSP images which allow treatment 
planning with small range uncertainties and very good dosimetric accuracy at a low physical and biological dose 
exposure.
4.1. Evaluation of iCT image quality
While all iCTs provided accurate RSP values (figure 1), differences mainly arise from variations in the path 
estimation accuracy and the number of particles at the investigated dose. Despite the most accurate path estimate, 
reduced statistics due to fragmentation and high stopping power cause an increased noise for cCT (figure 1(H)). 
The implemented CSP offers similar accuracy as the computationally more demanding most likely path and is 
superior to a straight path even for cCT, despite the substantially reduced MCS (Collins-Fekete et al 2017a).
The use of a hull contour for the CSP estimation is of fundamental importance (Collins-Fekete et al 2017b). 
Although the selected approach exploited prior knowledge, an approximated image reconstructed along straight 
trajectories (Shrestha et al 2018) or geometrically (Giacometti et al 2017) could be alternatively used.
Phys. Med. Biol. 64 (2019) 125008 (10pp)
5S Meyer et al
The increased RSP relative error for heterogeneities (figure 1(J), slice 28–35) originates from the reduced RSP 
accuracy for bone and low-HU regions (figure 2) caused by partial volume effects and path estimation inaccura-
cies. The latter is related to the assumption of homogenous water in the CSP model (Collins-Fekete et al 2015). 
Both effects are enhanced for pCT due to increased scattering. In contrast, for soft tissue, the path estimations 
are comparably accurate for all ions. Here, pCT provides superior accuracy due to less noise from an increased 
number of particles at the same imaging dose. This is supported by the large RSP error of pCT compared to heCT 
and cCT observed at the same particle statistics. The remaining RSP inaccuracy (figure 2) introduced by the 
reconstruction demonstrates the current limitation of iCT even for an ideal setup.
4.2. Assessment of range accuracy
Figure 3 illustrates the influence of RSP errors on the dose calculation accuracy in different anatomical regions. 
Overall, heCT showed superior performance since it is less affected by heterogeneities than pCT and offers high 
RSP accuracy for soft tissue (figure 2), representing the main penetration medium. The achieved range accuracy 
of better than 0.4% surpasses the uncertainty of xCT being typically 1%–3% (Yang et al 2012) and  −1.00% in 
the presented case. The xCT range shift is comparable to those found by Wohlfahrt et al (2017) for a comparison 
with dual-energy CT based RSP estimation, reporting average shifts significantly larger than 1%. A negative sign 
(i.e. range underestimation) is expected since the beam mainly penetrates soft tissue, which has systematically 
larger RSP than the reference. This demonstrates that iCT could potentially provide reduced range uncertainties 
for proton therapy treatment planning for the considered anatomical locations compared to xCT. However, 
experimental realizations are not yet addressed by this theoretical study. Potentially reduced gain in treatment 
plan quality is expected due to the degraded image quality for a realistic detector system. The RSP accuracy is 
mainly influenced by the water-equivalent path length (WEPL)  resolution of the residual range/energy detector. 
However, if the WEPL resolution is close to the intrinsic range straggling limit, e.g. around 3 mm for 200 MeV 
protons (Bashkirov et al 2016), the MC simulations implicitly embed this uncertainty and therefore its impact 
on RSP accuracy. The spatial resolution is limited by the ion track estimation accuracy which depends on the 
Figure 1. Comparison of axial slices of reconstructed iCTs and the RSP relative error. For slices 8 and 25 of Pat1, ground truth ((A) 
and (E)) , pCT ((B) and (F)), heCT ((C) and (G)) and cCT ((D) and (H)) are shown. (I)–(K) show the errors for Pat1, Pat2 and Pat3, 
respectively. The corresponding anatomical regions for selected slices are shown above the plots. 
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location and properties of the tracking detectors, and the intrinsic inaccuracy of the employed path model. 
While the latter is included in our study, spatial resolution and material budget of typical pCT prototypes will 
cause an average position uncertainty of 0.7 mm (Bopp et al 2014). Heavier particles will benefit from reduced 
scattering in the innermost tracker halves, being a further argument in favor of helium ions compared to protons. 
Additionally, fragmentation within the detector material will further degrade the available particle statistics, thus 
increasing the necessary imaging dose in order to safeguard the same image quality.
The general range underestimation is related to an average RSP overestimation, which in turn might have two 
potential underlying causes. First, the conversion of the energy loss of each individual ion into integrated RSP is 
based on the Bethe-Bloch formula, neglecting energy loss due to other interaction types (e.g. nuclear reactions). 
Figure 2. Joint histogram of the reconstructed iCTs and the original HU values, shown in steps of 20 HU values. The colored solid 
lines correspond to the mean value while partially-transparent shaded areas represent the  ±3 standard deviation interval. An outline 
is added to improve the visibility of overlapping regions. The black line indicates the ground truth conversion curve being used to 
import the initial xCT into the simulation.
Figure 3. Beam’s-eye view water-equivalent proton range variations for recalculation based on iCTs and xCT with respect to the 
optimized dose using the reference plan. On the left, the 80% isodose contours are overlaid with the ground truth radiographies. 
Positive and negative differences indicate an over- and under-ranging, respectively.
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However, the resulting overestimation effect is small, since the applied data cuts (Schulte et al 2008) should have 
removed the majority of events with nuclear collisions and large-angle MCS. Secondly, the fit factors of the CSP 
model have some uncertainty and simply assume uniform homogenous material (Collins-Fekete et al 2015). 
Therefore, the scattering and consequently the path segment length in bone is underestimated, causing an RSP 
overestimation (neglecting partial volume effects). Generally, the RSP overestimation for very small HU values 
seems to be mostly compensated by the underestimation for bone regions.
4.3. Comparison of dosimetric outcome
Figure 4 compares the impact of range calculation uncertainties on the dose distribution for clinical proton 
therapy plans. The very promising dosimetric outcome is confirmed by high gamma passing-rates, which are in 
agreement with the observed range accuracy (figure 3). Variations between the different ions were not substantial 
due to similar RSP accuracies (figure 1) and relatively robust treatment plans.
This demonstrates the potential of iCT as a replacement for x-ray imaging. However, various clinical studies 
have already shown that recent developments in x-ray imaging technology like dual-energy CT can also provide 
improved treatment planning accuracy (Wohlfahrt et al 2017). While those devices already exist as clinical prod-
ucts, they are typically not integrated at isocenter and the RSP accuracy should still be theoretically inferior to 
iCT (Hansen et al 2015).
Integrating iCT into clinical practice will require a dedicated and adjusted work-flow. Even though iCT ena-
bles improved density resolution (Schulte et al 2005), the contrast might be insufficient for accurate tumor detec-
tion and delineation. High-density contrast agents like gold nanoparticles (Hainfeld et al 2006) could in prin-
ciple provide sufficient contrast enhancement if the cellular intake is appropriate (Schulte et al 2004). iCT will 
potentially allow us to perform treatment delivery and planning inside the treatment room without requiring 
repositioning of the patient or additional imaging technology. This will avoid further range uncertainties if fast 
solutions for image reconstruction (e.g. GPU implementations (Karonis et al 2013)), as well as delineation and 
treatment planning, are available.
Figure 4. Proton beam arrangement (red arrows) and corresponding dose-volume histograms for the optimized (ground truth) 
and recalculated (iCT and xCT) dose distributions of Pat1 ((A) and (D)), Pat2 ((B) and (E)) and Pat3 ((C) and (F)).
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4.4. Estimation of biological dose exposure
Table 1 summarizes the RMF model predictions of the RBE for cell death for the different iCT simulations. The use 
of a diagnostic x-ray imaging spectrum as reference radiation allows us to evaluate radiobiological implications 
encountered when using iCT as a replacement of xCT for treatment planning imaging. The considerable 
changes in RBEDSB with reference radiation are in agreement with a previously reported value of 1.259 for the 
RBEDSB of 130 kVp x-rays relative to 60Co γ-rays (Stewart et al 2015). In general, all RBEDSB values relative to 
the 130 kVp x-ray spectrum were below 1, indicating reduced radiobiological implications compared to x-ray 
imaging, since the patient is solely receiving dose from the low-LET region of the Bragg-curve plateau. The 
processing of DSBs into chromosome aberrations is widely considered a dominant mechanism for reproductive 
cell death and radiation induced carcinogenesis (Byrne et al 2014). We consider the latter of great importance 
and as a major biological endpoint for imaging applications.
In addition, RBERMF directly provides an estimate of the RBE for reproductive cell death based on the LQ 
model. While this formalism is well established at treatment doses, an underestimation of the radiation effects, 
the so-called low-dose hyper-radiosensitivity (Marples and Collis 2008), may occur below 1 Gy. Therefore, there 
is some uncertainty in the LQ/RMF RBE estimates under the investigated conditions. In addition, we are not 
attempting to estimate absolute survival, rather a relative measure of biological effectiveness between different 
particles at the same dose level.
The used RMF model estimations implicitly included δ-rays since the MCDS is tuned to experimental data 
and track structure simulations. Accordingly, the MC simulations used a continuous-slowing-down-approx-
imation. For clinical energies, this approach results in dose variations below 0.7% compared to the explicit track-
ing of delta electrons (Mairani et al 2010). Despite the range of secondary electrons up to several millimeters in 
the iCT energy regime, the dose discrepancy is still small, with maximum variations of 0.2 mGy for cCT.
The sparse availability of data on biological effects for typical imaging doses imposes an important limita-
tion for the presented study. However, experimental data used for validating the MCDS algorithm indicate that 
the number of γ-H2AX foci is linearly correlated with DSB induction for a dose range of approximately 1 mGy 
up to 2 Gy (Rothkamm and Löbrich 2003, Stewart et al 2011). While measurements have not necessarily been 
performed for every ion type over these dose ranges, there is strong experimental and theoretical evidence that 
DNA damage is a linear function of absorbed dose from ~1 mGy to 1000 Gy for all types of ions and energies. The 
cell survival at typical imaging doses might be affected by low-dose hyper-radiosensitivity observed for low- and 
high-LET radiation (Marples and Collis 2008). However, in this study our particular interest is in relative biologi-
cal effects, rather than absolute. The relative yield of damage (RBEDSB) is less sensitive to factors such as low-dose 
hyper-radiosensitivity, cell proliferation, cycle effects or measurement artifacts. Furthermore, it is the relative 
DSB yield that plays a significant role in the RMF model rather than the absolute number of DSBs per cell.
In the absence of experimental or clinical data, theoretical models represent a guidance in investigating the 
radiation biology of low-dose imaging. The presented simulation study represents a first theoretical step in eval-
uating the biological effects of iCT imaging, whereas future clinical applications for human patients will require 
a careful experimental validation of potential biological effects. The RMF model in combination with MCDS 
has been previously compared to experimental data and other clinically established models for various ion types 
(Semenenko and Stewart 2006, Carlson et al 2008, Stewart et al 2011, Frese et al 2012, Kamp et al 2015, Mairani 
et al 2016, Stewart et al 2018). The RMF model facilitates an online adaption of the biological modeling (Kamp 
et al 2017) without repeating the physical dose calculation, i.e. the computationally expensive MC simulations. 
Additionally, the RMF/MCDS approach provides information about both cell survival and DNA damage induc-
tion. This allows for the investigation of different biological endpoints, reference radiation qualities and tissue 
Table 1. Estimated mean RBE in the total imaging volume of the iCT simulations. RBERMF is the RBE for cell death predicted by the RMF 
model for assumed reference tissue radiosensitivity of α/β   =  2 Gy and α/β   =  10 Gy. RBEDSB is the RBE for DNA double-strand break 
induction using the MCDS algorithm.
Proton-CT Helium-CT Carbon-CT
Patient RBE2GyRMF RBE
10 Gy
RMF RBEDSB RBE
2Gy
RMF RBE
10 Gy
RMF RBEDSB RBE
2Gy
RMF RBE
10 Gy
RMF RBEDSB
Reference radiation: 60Co
Pat1 1.138 1.055 1.034 1.192 1.089 1.064 1.381 1.240 1.205
Pat2 1.126 1.051 1.032 1.188 1.090 1.065 1.386 1.243 1.208
Pat3 1.126 1.052 1.032 1.182 1.087 1.063 1.379 1.240 1.205
Reference radiation: 130 kVp
Pat1 0.850 0.823 0.816 0.888 0.849 0.840 1.026 0.966 0.951
Pat2 0.843 0.821 0.815 0.886 0.850 0.841 1.029 0.969 0.954
Pat3 0.843 0.821 0.815 0.882 0.848 0.839 1.024 0.966 0.952
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radiosensitivity parameter combinations in order to estimate the range of variations of expected complications, 
considering the potential limitations of the radiobiological model at the given dose.
5. Conclusion
Our study quantitatively demonstrated that under ideal conditions iCT can enable an accurate assessment 
of clinical RSP values, showing the highest accuracy for heCT. In addition, the associated treatment planning 
comparison demonstrates improvements in dosimetric accuracy and range accuracy superior to uncertainties 
caused by the HU-RSP conversion for xCT. This would allow for reduced safety margins, ultimately limiting 
normal tissue damage and improving dose conformality for patient treatments. The RBE predictions using the 
RMF model indicated that iCT has reduced radiobiological effects compared to typical xCT spectra for treatment 
planning. Therefore, with proper detector development enabling to achieve results close to the presented intrinsic 
capabilities, iCT has the potential to replace x-ray imaging for ion-beam therapy treatment planning.
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